Clarity Pharmaceuticals Știri Eulerpool

Clarity Pharmaceuticals Eulerpool News

Clarity Pharmaceuticals Știri Acțiune

Clarity Pharmaceuticals este urmărit de numeroși jurnaliști și investitori din întreaga lume. Cele mai recente Clarity Pharmaceuticals știri le adunăm aici.

• 15 martie ·

  Yahoo
  Clarity's theranostic prostate cancer trial advances to multi-dose phase
• 8 martie ·

  Yahoo
  Additional COBRA results: SAR-bisPSMA detects lesions in the 2-millimetre range
• 22 decembrie ·

  Yahoo
  First patient dosed in Clarity's registrational Phase III prostate cancer trial with Cu-64 SAR-bisPSMA
• 30 noiembrie ·

  Yahoo
  Registrational Phase III CLARIFY trial in prostate cancer commences
• 30 noiembrie ·

  Yahoo
  First patient with metastatic prostate cancer to receive 2 doses of Cu-67 SAR-bisPSMA achieves undetectable PSA level
• 7 noiembrie ·

  Yahoo
  Recruitment target achieved for Phase II SAR-Bombesin prostate cancer trial
• 26 octombrie ·

  Yahoo
  Clarity and PSI kick off SAR-bisPSMA Phase III
• 3 octombrie ·

  Yahoo
  First patient treated with Cu-67 SAR-Bombesin in theranostic prostate cancer trial
• 10 august ·

  Yahoo
  Clarity's theranostic prostate cancer trial advances to highest dose level
• 4 iulie ·

  Yahoo
  Positive guidance from US FDA on Cu-64 SAR-bisPSMA Phase III trial in prostate cancer